Adult & Child Center for Outcomes Research and Delivery Science
minute read
"It looks as if a third dose may be in the future for children 5 to 11 as well," said Dr. Sean O'Leary, a pediatric infectious disease specialist and ACCORDS investigator.
Topics: Press Coverage
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
